Background/Aims: In diabetic ventricular myocytes, transient outward potassium current (I to ) amplitude is severely reduced because of the impaired catecholamine release that characterizes diabetic autonomic neuropathy. Sympathetic nervous system exhibits a trophic effect on I to since incubation of myocytes with noradrenaline restores current amplitude via beta-adrenoceptor (βAR) stimulation. Here, we investigate the intracellular signalling pathway though which incubation of diabetic cardiomyocytes with the βAR agonist isoproterenol recovers I to amplitude to normal values. Methods: Experiments were performed in ventricular myocytes isolated from streptozotocin-diabetic rats. I to current was recorded by using the patch-clamp technique. Kv4 channel expression was determined by immunofluorescence. Protein-protein interaction was determined by coimmunoprecipitation. Results: Stimulation of βAR activates first a Gαs protein, adenylyl cyclase and Protein Kinase A. PKA-phosphorylated receptor then switches to the Gαi protein. This leads to the activation of the βAR-Kinase-1 and further receptor phosphorylation and arrestin dependent internalization. The internalized receptor-arrestin complex recruits and activates cSrc and the MAPK cascade, where Ras, c-Raf1 and finally ERK1/2 mediate the increase in Kv4.2 and Kv4.3 protein abundance in the plasma membrane. Conclusion: β 2 AR stimulation activates a Gαs and Gαi protein dependent pathway where the ERK1/2 modulates the Ito current amplitude and the density of the Kv4.2 and Kv4.2 channels in the plasma membrane upon sympathetic stimulation in diabetic heart.
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Cardiomyocyte isolation Healthy (control) and diabetic rats were anaesthetized by intraperitoneal injection of chloral hydrate (3 ml/kg). The hearts were removed and perfused with a Tyrode solution containing (in mmol/l): NaCl 118, KCl 5.4, NaHCO 3 24 , MgCl 2 1.02, CaCl 2 1.8, NaH 2 PO 4 0.42, dextrose 20 and taurine 20, bubbled with 95% O 2 and 5% CO 2 , pH 7.4 at 37°C, followed by the same solution without Ca 2+ , and by the same nominally Ca 2+ -free solution containing collagenase Type I (0.5 mg/ml) and protease Type XIV (0.03 mg/ml). Next, the hearts were perfused with a KB solution (in mmol/l): taurine 10, glutamic acid 70, creatine 0.5, succinic acid 5, dextrose 10, KH 2 PO 4 10, KCl 20, HEPES-K + 10, EGTA-K + 0.2, adjusted to pH 7.4 with KOH. Last, cardiomyocytes were obtained by mechanical agitation of the ventricles.
Incubation with inhibitors and activators
Aliquots of the KB solution containing the myocyte suspension were incubated for ~20 hours (18) (19) (20) (21) (22) (23) (24) at 4°C with either isoproterenol, dissolved in deionized water plus ascorbic acid, (Sigma Chemical Co.), vehicle, forskolin or isoproterenol plus each of the following compounds: 8-Br-cAMP, 2´,3´-DDOA, FTP Inhibitor III, PD98059, H-89, β-ARK1 Inhibitor, PP2 (Calbiochem); choleric toxin (Gentaur); GW5074, pertussis-toxin or concanavalin A (Sigma Chemical Co.).
Electrophysiological recordings
Cells were transferred to a shallow chamber, mounted on the stage of an inverted microscope Olympus CK2. The cells were allowed to settle for at least 10 min before being superfused with the external bathing solution. For the experiments we used only Ca 2+ -tolerant rod-shaped cells, with clear cross-striations and lacking any visible blebs on their surfaces. All experiments were performed at room temperature (20-22°C) .
Ionic currents were recorded using the whole-cell configuration of the Patch-Clamp technique with an Axopatch 200B patch-clamp amplifier (Axon Instruments Inc.). Recording pipettes were obtained from borosilicate tubes (Sutter Instruments), and had a tip resistance of 1-3 MΩ when filled with the internal solution (in mmol/l): L-aspartic acid (potassium salt) 80, KH 2 PO 4 10, MgSO 4 1, KCl 50, HEPES-K + 3, ATP-Na 2 3, EGTA-K + 10, adjusted to pH 7.2 with KOH. Following the patch rupture, whole cell membrane capacitances were measured from integration of the capacitive transients elicited by voltage steps from -50 to -60 mV, which did not activate any time dependent membrane current. Series resistances were compensated 80% in order to minimize voltage errors and were checked regularly throughout the experiment. The voltage-clamp experimental protocols were controlled with the "Clampex" program of the "pClamp 10.2" software (Axon Instruments Inc). The external bathing solution was (in mmol/l): NaCl 86, MgCl 2 1, HEPES-Na + 10, KCl 4, CaCl 2 0.5, CoCl 2 2, dextrose 12, TEA-Cl 50, adjusted to pH 7.4 with NaOH. I to was recorded applying depolarizing pulses to +50 mV, starting from a holding potential of -60 mV. Pulses were applied at a frequency of 0.1 Hz to ensure the full recovery of I to from inactivation. The TEA-resistant time-independent I ss was digitally subtracted and peak I to minus I ss were normalized to cell capacitance, and expressed as pA/pF.
Immunofluorescence
Freshly isolated ventricular cardiomyocytes were placed on tissue culture plates containing poly-Llysine coated round coverslips. There, cells were incubated for 20 hours at 4°C with vehicle or isoproterenol. Cells in coverslips were then fixed in methanol during 10 min and washed with phosphate buffer before incubation for 1 hour at room temperature in blocking buffer (0.22% gelatine, 1% BSA, 0.1% Triton X-100 and 1% normal donkey serum in phosphate buffer). Primary anti-Kv4.2 and Kv4.3 (Santa Cruz Biotechnology) and secondary donkey anti-goat Alexa 488 (Invitrogen) antibodies diluted in blocking buffer were applied for 60 and 45 min, respectively. Coverslips were mounted in Mowiol reagent (Calbiochem) and analysed in a Leica LCS SP2 AOBS fluorescence microscope.
Immunoprecipitation
All procedures were performed at 4°C, in a homogenization buffer (HF) containing Tris-HCl 20 mmol/l pH 7.4, EDTA 1 mmol/l, and 2.5 µl/ml of the Sigma Protease inhibitor cocktail (Sigma Chemical Co.). Myocytes were homogenized 1 minute on ice. Nuclei and debris were pelleted by centrifugation at 500g for 10 minutes. The protein content was determined by using the Bradford method [21] . Cellular Physiology and Biochemistry
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Myocytic samples were solubilized in RIPA buffer (Tris-HCl 50 mmol/l pH 7.4, NaCl 150 mmol/l, EDTA 1 mmol/l, Igepal 0.5%, Sodium deoxycholate 1 %, 2.5 µl/ml of the Sigma Protease inhibitor cocktail and the crosslinker DTBP 0.5 mg/ml). 1 mg of proteins were centrifuged at 25000g for 30 min. The pellet was resuspended in 150 µl of RIPA buffer and incubated for 1 hour at 4°C. Samples were cleared by centrifugation at 15000g for 25 minutes and supernatants were incubated for 3 hours at 4°C with 40 µl of protein G-sepharose. Next, samples were centrifuged 2 minutes at 4000g. 150 µl of the supernatant were obtained and incubated overnight with 2 µg of a mouse monoclonal anti-βArrestin-1/2 antibody (Santa Cruz Biotechnology) in 140 µl of RIPA at 4°C. 100 µl of 50% protein G-sepharose were added and the mixture was incubated for 3 hours at 4°C. The beads were pelleted and washed three times in RIPA buffer at 4000g for 2 minutes. The bound proteins were eluted using 50 µl of SDS sample buffer. The pellet from each immunoprecipitation experiment was probed with Arrestin as control, and with each one of the proteins of interest. 
Western blot

Data analysis
Current recordings were analyzed using the Clampfit program of pClamp 10.2 software (Axon Instruments Inc.). No leaks or capacitive subtractions were used during the experiment or during digital analysis, and cells with very slow capacitive transients or with evident current leak were eliminated.
Data are expressed as mean ± SEM. Multiple comparisons were made using ANOVA and Bonferroni's method. A p value of <0.05 was considered as statistically significant.
Results
Long term incubation with isoproterenol restores I to amplitude in diabetic cardiomyocytes
We have previously described that norepinephrine acutely reduces I to current density in myocytes isolated from healthy rats and this effect is mediated by stimulation of α1-adrenoceptors [3, 9] .
In a previous work we also showed that incubation with noradrenaline for 24 hours restored I to current amplitude in diabetic cardiomyocytes. This effect was mediated by βARs, as incubation with the β-antagonist propranolol prevented the effect, whereas the α-blocker prazosin did not [3] . To determine the appropriate concentration of β-agonist, we performed titration experiments, where I to current was recorded after incubating the cells for 20 hours at 4°C with increasing concentrations of isoproterenol.
In Figure 1 we show that, as expected, cardiac myocytes isolated from diabetic rat hearts showed current densities significantly smaller than those obtained from healthy cells (13.9±1.0 vs. 21.9±1.1 pA/pF, n=25 and 23 respectively, p<0.0001). The concentration response relationship showed the classical bell shape of β-adrenergic receptors [22] . Incubation with isoproterenol 1 nM restored I to density up to control values (23.8±2.3 pA/pF, n=13, p<0.0001 compared to diabetic cells). However, neither higher nor lower concentrations of the agonist fully recovered current amplitude (Fig. 1B, 1C) . We therefore chose the 1 nM concentration for the subsequent experiments.
In a control experiment (Fig. 1C) we incubated healthy myocytes with 1 nM isoproterenol for 20 h and observed no effect on current amplitude (20.37±2.7 pA/pF , n=9) compared to 
Diabetes reduces Kv4.2 and Kv4.3 protein abundance in the cell membrane and this effect is recovered by incubation with isoproterenol
One of the abnormalities associated with diabetic cardiomyopathy is a decreased expression of genes encoding potassium channels. The subsequent reduction in channel protein amount may be responsible for the reduced potassium currents and for the lengthening in action potential duration observed in the diabetic heart [7, 23] . Thus, downregulation of Kv2.1, Kv4.2 and more controversially Kv4.3 expression has been reported in rat ventricle in mild type I diabetes models [23, 24] .
We tested whether diabetes reduces I to channels levels in diabetic myocytes and if βAR stimulation could increase them. Cardiomyocytes isolated from healthy and diabetic rats were seeded in coverslips and incubated in the presence or absence of isoproterenol 1nM for 20 hours. Cells were then stained with immunofluorescent antibodies against Kv4.2 and 
Kv4.3 proteins and samples were analyzed by fluorescence microscopy. Kv4.2 and Kv4.3 channel abundance were reduced in diabetic compared to healthy myocytes. However, diabetic myocytes incubated with isoproterenol showed normal channel protein abundance, similar to healthy cells (Fig. 2) . These results indicate that βAR stimulation restores the amount of Kv4.2 and Kv4.3 proteins in the cell membrane and therefore restores I to current density. The following experiments aimed to identify the functional signalling pathway that connects βAR activation with the restoration of Kv4.3 and Kv4.2 channels.
Isoproterenol activates Gαs-AC-cAMP-PKA pathway in diabetic cardiomyocytes
βARs belong to the G protein-coupled receptor superfamily and the major subtypes expressed in the mammalian heart are β 1 and β 2 . β 1 is the most abundant beta subtype in the heart, but β2 is not less physiologically relevant as it can, for instance, protect cardiac myocytes from cell death after ischemia and reperfusion injury [25] . Although they differ in physiological roles and pharmacological properties, both activate the classic Gαs-AC-cAMP-PKA pathway, whereas only β2 activates also Gαi protein [reviewed in 26]. We tested the implication of the classic pathway in the trophic effect on I to by incubating diabetic ventricular myocytes with isoproterenol together with specific blockers or vehicle. As Figure 3 shows, inhibition of either Gαs by choleric toxin or adenylyl cyclase by 2´,3´-DDOA prevented the isoproterenol-induced restoration of I to density (11.2±1.5 pA/pF, n=14, p<0.0001 and 13.7±0.9 pA/pF, n=13, p=0.0004 respectively). Similar results were obtained after protein kinase A blockade by H-89 (12.8±1.2 pA/pF, n=18, p<0.0001).
To further test the involvement of the AC, we incubated diabetic cells with the adenylyl cyclase activator forskolin expecting that this would reproduce the isoproterenol-mediated effects. Interestingly, forskolin showed different results depending on the concentration used. The 1 nM concentration only slightly recovered the I to density (14.7±1.9 pA/pF, n=13, ns with respect to diabetics), 10 nM partially restored I to density (18.2±1.3 pA/pF, n=24, p<0.0001 compared to diabetic cells) but, 100 nM had no effect on the current, which remained significantly reduced (12.3±0.9 pA/pF, n=15, ns with respect to diabetics). One possible explanation of this paradox is that high concentrations of forskolin might inhibit downstream components of the pathway such as c-Raf1 [27] , as will be discussed below. Cellular Physiology and Biochemistry
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In order to avoid this experimental shortcoming, we used 8BrcAMP, a non-hydrolizable analogue of cAMP. We incubated myocytes isolated from diabetic rats with 8BrcAMP 10 µM and observed that it restores I to density to control values (19.7±1.1 pA/pF, n=10, n.s.).
Gαi protein activation and receptor internalization are also required to restore I to amplitude
After activating the Gαs-AC-PKA pathway, β 2 ARs can also couple to the pertussis-toxinsensitive Gαi proteins [28] . Upon Gαi protein activation, the released βγ subunits activate the β-adrenoceptor kinase 1 [29, 30] . This G protein-coupled receptor kinase (GRK2 or β-ARK1) phosphorylates the activated βAR, resulting in receptor desensitization and arrestindependent internalization. We wondered whether activation of Gαi protein, release of βγ complex and further GRK-mediated phosphorylation and internalization of the β-AR were involved in the isoproterenol-mediated recovery of I to current density (Fig. 4) . To answer this question we first blocked the Gαi heterotrimeric protein activation using pertussis toxin and found that isoproterenol did not restore the I to amplitude in diabetic cells (7.8±4.1 pA/ pF, n=14, p=0.0027). In addition, when Gαi protein is blocked by a 2h preincubation with PTX, incubation with 8BrcAMP for 20h does not recover the current density (11.8±1.68 pA/ pF, n=12, p<0.001). 5 . Formation of the β 2 AR complex in stimulated diabetic ventricular myocytes. Ventricular myocytes isolated from diabetic hearts were stimulated for 5 minutes with isoproterenol 1 nM. After that, β-Arrestin was immunoprecipitated from myocytic samples with protein G-sepharose. The pellet from each immunoprecipitation experiment was probed with β-arrestin as control. β 2 AR and the downstream effector cSrc also coimmunoprecipitate with arrestin. Each image corresponds to representative western blots from 3 immunoprecipitation experiments. When possible, the western blotting antibodies were raised in different species than that used for immunoprecipitation to skip the IgGs band.
We then inhibited the βAR phosphorylation by using β-ARK1 inhibitor. Again, we observed no restoration of I to density in isoproterenol-treated diabetic myocytes (11.7±1.3 pA/pF, n=14, p<0.0001). Finally, we blocked the internalization of the phosphorylated βAR using the endocytosis inhibitor concanavalin A and obtained similar results (9.6±1.0 pA/ pF, n=14, p=0.0002). Taken consequently, these results indicate that both Gαs and Gαi pathways are required to increase the I to current density in the diabetic myocardium upon isoproterenol treatment.
The β2AR-Arrestin-cSrc complex is functional in diabetic myocytes Stimulation of MAP kinase pathway by β 2 ARs is mediated by the βγ complexes from Gαi proteins through a pathway involving the recruitment of the tyrosine kinase cSrc by the βAR-Arrestin complex and the subsequent activation of the low-molecular-mass G protein Ras [31, 32] . As MAP kinase pathway increases the expression of certain proteins, one possibility is that in diabetic cardiac cells βAR stimulation leads to an increase on Kv4.2 and Kv4.3 channels in the cell membrane by activating Src-MAPK cascade.
To confirm this hypothesis we tested the formation of the β 2 AR-Arrestin-cSrc complex. Diabetic myocytes were incubated with isoproterenol in order to activate the beta receptor and then Arrestin was immunoprecipitated. We performed incubations with isoproterenol for 0, 5, 10, 15, 20, 30 and 60 minutes, as well as for 18 hours. However, we only observed the β 2 receptor and the cSrc proteins in the pellet of the 5 minute incubation group (Fig. 5) . Coimmunoprecipitation experiments in the rest of the groups were negative (data not shown) indicating the transient nature of the interaction.
Internalized βAR-cSrc complex activates MAPK pathway and thus restores I to current One of the possible targets of internalized β 2 AR is the Mitogen-Activated Protein (MAP) kinase pathway. MAP kinases can phosphorylate transcription factors and regulate transcription. In a classical MAP kinase pathway an external signal activates the MAP kinase kinase kinase c-Raf-1. This phosphorylates the MAP kinase kinase MEK1/2 which then phosphorylates ERK1/2, the last cytoplasmic kinase in the cascade [reviewed in 33] .
We tested this hypothesis by incubating the cells with isoproterenol while blocking the pathway at different levels. In a first group of experiments we used either the cSrc tyrosine kinase inhibitor PP2 or the Ras blocker FPT inhibitor III (13.1±1.5 pA/pF, n=9, p=0.0022 Discussion β-adrenoceptors are major regulators of cardiac physiology as they mediate catecholamine-induced inotropic, chronotropic and lusitropic responses. Therefore, βARs transduction pathways have been extensively studied. However, our results describe for the first time the necessity of Gαs, Gαi and ERK activation for the isoproterenol-induced increase of Kv4.2 and Kv4.3 proteins in the cell membrane, providing a mechanism for the trophic effect of the sympathetic nervous system on I to current in type I diabetes.
Dual coupling of β 2 ARs to Gαs and Gαi proteins have been described in cultured cells as well as in reconstituted systems [26, 34, 35] . Moreover, Gαs to Gαi switching mediates the isoproterenol-induced cardiac hypertrophy in neonatal rats [36] . Our results show that this dual coupling is also active in adult cardiomyocytes isolated from diabetic rats. Like in cardiac hypertrophy, incubation with isoproterenol activates first Gαs and then Gαi signalling pathways, leading to the activation of ERK kinase and, eventually, to an increase in Kv4 proteins in the plasma membrane in the type I diabetes.
Whereas some authors postulate that PKA-mediated βAR phosphorylation is a critical step for internalization, G protein switching and activation of ERK1/2 kinases [34, 35] , others propose that ERK activation is PKA-independent [37] . We have observed that adenylyl cyclase and PKA inhibition prevent isoproterenol-induced I to restoration. This result indicates that protein kinase A is required for the increase in Kv4.2 and Kv4.3 protein levels. A reasonable explanation is that PKA phosphorylates the βAR, targets it for internalization and redirects the signalling pathway towards ERK activation. However, PKA might activate the MAP kinase pathway through a downstream mechanism different from βAR phosphorylation. This mechanism usually involves the PKA-dependent activation of Rap-1 thereby activating Src. However, Rap-1 is not found in ventricular myocytes. The alternative hypothesis is that two kinases, PKA and β-ARK1, contribute to phosphorylate and regulate the βAR. Consistent with this, we have found that isoproterenol also fails to restore I to current density when the G protein receptor kinase β-ARK1 is inhibited. Once activated, the Gαi protein releases its βγ subunits activating ERK. However, the inhibition of AC activity by Gαi might contribute to this effect. In this regard, it has been reported that activation of PKA inhibits activation of c-Raf-1 [27, 38] and thus, increased concentration of cAMP inhibits MAP kinase activity. Therefore, inhibition of AC might relieve the inhibitory effect of PKA on Ras allowing the sequential activation of c-Raf-1 and the other members of the MAP kinase pathway. This is consistent with our results with the AC activator forskolin. In cells incubated with forskolin 10 nM but not 100 nM, the isoproterenolinduced restoration of I to amplitude was complete. Thus, whereas the low concentration of forskolin (10 nM) could facilitate the G protein switching required for ERK activation, high concentrations (100 nM) might cause an exaggerated PKA activation that inactivates Raf1.
Taken together our results agree with the model proposed by Luttrell et al. [32] in cell cultures overexpressing the beta adrenoceptors. Thus, in diabetic cardiomyocytes β 2 AR stimulation activates the Gαs protein, adenylyl cyclase and PKA. The PKA-phosphorylated receptor then switches to a Gαi protein whose βγ complex activates β-ARK1. Once dually phosphorylated by PKA and β-ARK1, the β 2 ARs internalizes in a process that requires Arrestin. The β 2 -Adrenoceptor-Arrestin complex recruits cSrc and activates Ras, which thereby activates MEK1/2 and finally ERK1/2. In our work, we found a physiological function for this intracellular pathway, where the MAPK cascade modulates the Kv4.2 and Kv4.3 protein levels in the cell membrane, and therefore I to current amplitude, in response to sympathetic stimulation (Fig. 7) . 
